Science Explorer Back to mapMap
Discussion
Researcher · BD Technologie (United States) · United States

John A. Mikszta

John A. Mikszta publishes mostly in Immunology, Pharmaceutical Science and Molecular Biology, on topics such as Immunotherapy and Immune Responses, Advancements in Transdermal Drug Delivery and Bacillus and Francisella bacterial research.

OpenAlex
World rank
#1,094,913
of 7,710,434 ranked researchers
Rank in United States
#354,432
of 1,627,098
Works
33
Citations
2.5k
Citations per work
75.8
h-index
22
i10-index 25Top 26% in Immunology
John A. Mikszta

What does John A. Mikszta research?

John A. Mikszta's work is mostly in Immunology and Microbiology (25%), Medicine (18%), Pharmacology, Toxicology and Pharmaceutics (12%).

Life Sciences: 16 works · 49.0% of their workImmunology and Microbiology: 8 works · 25.0% of their workImmunology: 8 works · 25.0% of their workPharmacology, Toxicology and Pharmaceutics: 4 works · 12.5% of their workPharmaceutical Science: 4 works · 12.5% of their workBiochemistry, Genetics and Molecular Biology: 4 works · 11.5% of their workMolecular Biology: 4 works · 11.5% of their workEverything else: 11 works · 33.3% of their workHealth Sciences: 6 works · 17.7% of their workMedicine: 6 works · 17.7% of their workEpidemiology: 2 works · 7.3% of their workDermatology: 2 works · 5.2% of their workInfectious Diseases: 2 works · 5.2% of their workTHEIR WORKJohn A. Mikszta33works
Life Sciences49%Health Sciences18%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Immunology and Microbiology825.0%
    2. Pharmacology, Toxicology and Pharmaceutics412.5%
    3. Biochemistry, Genetics and Molecular Biology411.5%
  2. Everything else1133.3%
    1. Medicine617.7%
  1. 1Immunology25% of their works
  2. 2Pharmaceutical Science12% of their works
  3. 3Molecular Biology12% of their works
  4. 4Epidemiology7% of their works
  5. 5Dermatology5% of their works
  6. 6Infectious Diseases5% of their works

Research topics

Which keywords describe John A. Mikszta's research?

The keywords of their largest research topics: Dendritic Cells, Immunity, Microneedles, Solid Lipid Nanoparticles, Anthrax, Tularemia, Natural Killer Cells and NK Cell Recognition.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 16 words, with their numbers
  1. Dendritic Cells101 topic
  2. Immunity101 topic
  3. Microneedles81 topic
  4. Solid Lipid Nanoparticles81 topic
  5. Anthrax71 topic
  6. Tularemia71 topic
  7. NK Cell Recognition61 topic
  8. Natural Killer Cells61 topic
  9. Foxp351 topic
  10. TGF-ß51 topic
  11. Chitosan41 topic
  12. Filaggrin41 topic
  13. Nanoparticles41 topic
  14. Skin Microbiome41 topic
  15. Yersinia pestis31 topic
  16. plague31 topic

Where does John A. Mikszta work?

John A. Mikszta's main affiliation in the publication record is BD Technologie (United States), United States.

How many publications and citations does John A. Mikszta have?

OpenAlex counts 33 works and 2,500 citations for John A. Mikszta, an h-index of 22, ranking #1,094,913 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about John A. Mikszta. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.